Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.
By S. Higgins, J. Hummel, I. Niazi, M. Giudici, S. Worley, L. Saxon, J. Boehmer, M. Higginbotham, T. De Marco, E. Foster and 1 more. Journal of the American College of Cardiology, 2003
755 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/e10e763167b4d6967062566ded99117cd4fa3435
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- The effect of cardiac resynchronization on morbidity and mortality in heart failure. (2005, background): “Median 66 67 Interquartile range 59–72 60–73 Male sex (%) 293 (73) 304 (74) NYHA class IV (%) 27 (7) 23 (6) Dilated cardiomyopathy (%) 193 (48) 177 (43) Ischemic heart disease (%) 144 (36) 165 (40) Heart disease of other causes (%) 67 (17) 67 (16) Heart rate (beats/min) Median 70 69 Interquartile ra”
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. (2007, result): “In the CONTAK-CD trial, significant reverse remodelling was observed in the small subgroup of patients in NYHA functional classes I–II after 6 months of CRT, although the benefits were less prominent than in the much larger group of patients in NYHA functional classes III–IV.(285) Similar observatio”
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) (2011, neutral): “Females, n (%) 394 (31) 59 (11)† 18 (8)† 41 (13)†”
- Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. (2008, background): “Reverse emodeling by CRT has previously been reported in smaller tudies of NYHA functional class II HF patients with 6 onths of follow-up (7,8).”